Gaskiya has a platform technology that will enable the development of a variety of robust, low-cost, rapid diagnostic kits for infectious disease detection. This technology will improve both the cost and effectiveness of RDT's to accelerate use in developing countries and enable their use in new industries. Initially, the tests will focus on Malaria and the Zika Virus for human testing and vibrio in oysters, but the platform will enable future diagnostics of many other infectious diseases affecting humans, animals and food sources.